Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Azacytidine and Phenylbutyrate in Severe Thalassemia
NCT00005934Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine, sodium phenylbutyrate in beta thalassemia, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jun 2000; status: completed.
02
Drugs
azacitidinesodium phenylbutyrate
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT00005934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005934.